Jesus M. González Moreno
Profile
Jesus M.
González Moreno worked as a Chief Medical Officer at Destiny Pharma Plc, Director-Global Clinical Development at Tigenix SAU, and Medical Director at AstraZeneca UK Ltd.
He holds a doctorate degree from the Universidad Autónoma de Madrid and a graduate degree from the Autonomous University of Barcelona.
Former positions of Jesus M. González Moreno
| Companies | Position | End |
|---|---|---|
Tigenix SAU
 Tigenix SAU Medical SpecialtiesHealth Technology Part of TiGenix NV, Tigenix SAU is a Spanish company that collects all the research and development of health, agri-food and industrial products from its partners. The company is based in Tres Cantos, Spain. The company has been driving biotechnology in Spain since 1999 and have more than 300 associated companies, startups, and entities. The group Zendal, a 100%% Spanish biopharmaceutical group, includes seven companies focused on manufacturing and commercializing high-value biotechnology products. Tigenix SAU is a member of AseBio, and the membership fees vary depending on the type of entity and the company's age, annual turnover, and equity. The company offers discounts and economic advantages to their members. The AseBio Investor Day is an investment forum that aims to connect the Spanish biotechnology industry with investors. | Chief Tech/Sci/R&D Officer | - |
AstraZeneca UK Ltd.
 AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
| DESTINY PHARMA PLC | Chief Tech/Sci/R&D Officer | - |
Training of Jesus M. González Moreno
| Universidad Autónoma de Madrid | Doctorate Degree |
| Autonomous University of Barcelona | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| DESTINY PHARMA PLC | Health Technology |
| Private companies | 2 |
|---|---|
Tigenix SAU
Tigenix SAU Medical SpecialtiesHealth Technology Part of TiGenix NV, Tigenix SAU is a Spanish company that collects all the research and development of health, agri-food and industrial products from its partners. The company is based in Tres Cantos, Spain. The company has been driving biotechnology in Spain since 1999 and have more than 300 associated companies, startups, and entities. The group Zendal, a 100%% Spanish biopharmaceutical group, includes seven companies focused on manufacturing and commercializing high-value biotechnology products. Tigenix SAU is a member of AseBio, and the membership fees vary depending on the type of entity and the company's age, annual turnover, and equity. The company offers discounts and economic advantages to their members. The AseBio Investor Day is an investment forum that aims to connect the Spanish biotechnology industry with investors. | Health Technology |
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Jesus M. González Moreno
